← All trials
NCT05594303
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 27, 2019
- Primary completion
- Jun 30, 2023
- Completion date
- Jan 31, 2024
- First posted
- Oct 26, 2022
- Last posted
- Oct 26, 2022
- Enrollment
- 24
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Guangzhou Medical UniversityLead sponsor
- Regend TherapeuticsCollaborator
- Guangzhou Medical UniversityOverall official - principal investigator
- Guangzhou Medical UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.